Tue, October 20, 2020

Difei Yang Initiated (BLUE) at Strong Buy and Held Target at $123 on, Oct 20th, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-123-on-oct-20th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Difei Yang of Mizuho, Initiated "bluebird bio, Inc." (BLUE) at Strong Buy and Held Target at $123 on, Oct 20th, 2020.

Difei has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 1 agrees with Difei's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $68 on, Monday, August 10th, 2020


These are the ratings of the 2 analyists that currently disagree with Difei


  • Matthew Luchini of "BMO Capital" Maintained at Buy with Decreased Target to $108 on, Thursday, August 6th, 2020
  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Decreased Target to $100 on, Monday, July 13th, 2020